Low bioavailability of rifampicin, one of the main antituberculous drug, stimulates searches of its new optimized formulations. The present study has showen possibility of rifampicin embedding into nanoparticles from plant phosphatidylcholine (diameter of 20-30 nm). Addition of sodium oleate to the phospholipid system caused a 2-fold increase of the percent of rifampicin incorporation. After oral administration to rats, the maximal drug observed in plasma one hour after was 0.5 and 4.2 mkg/ml for free rifampicin for rifampicin in phospholipids-oleate nanoparticles, respectively. These levels were maintained for more than two hours of the experiment. High rifampicin bioavailability in the oleate containing phospholipid nanosystem suggests prospectivity of its pharmaceutical elaboration.
Sanzhakov M.A., Prozorovskyi V.N., Ipatova O.M., Tikhonova E.G., Medvedeva N.V., Torkhovskaya T.I. (2013) Drug delivery system on the base of phospholipid nanoparticles for rifampicin. Biomeditsinskaya Khimiya, 59(5), 585-590.
Sanzhakov M.A. et al. Drug delivery system on the base of phospholipid nanoparticles for rifampicin // Biomeditsinskaya Khimiya. - 2013. - V. 59. -N 5. - P. 585-590.
Sanzhakov M.A. et al., "Drug delivery system on the base of phospholipid nanoparticles for rifampicin." Biomeditsinskaya Khimiya 59.5 (2013): 585-590.
Sanzhakov, M. A., Prozorovskyi, V. N., Ipatova, O. M., Tikhonova, E. G., Medvedeva, N. V., Torkhovskaya, T. I. (2013). Drug delivery system on the base of phospholipid nanoparticles for rifampicin. Biomeditsinskaya Khimiya, 59(5), 585-590.
Ranganathan R., Madanmohan S., Kesavan A., Baskar G., Krishnamoorthy Y.R., Santosham R., Ponraju D., Rayala S.K., Venkatraman G. (2012) Int. J. Nanomedicine, 7, 1043-1060. Scholar google search
Dube D., Agrawal G.P., Vyas S.P. (2012) Drug Discov Today, 17(13-14), 760-773. Scholar google search
du Toit L.C., Pillay V., Danckwerts M.P. (2006) Respir Res., 7(1), 118. Scholar google search
Sosnik A., Carcaboso A.M., Glisoni R.J., Moretton M.A., Chiappetta D.A. (2010) Adv. Drug Deliv. Rev., 62(4-5), 547-559. Scholar google search
Sarfaraz M.D., Hiremath D., Chowdary K.P.R. (2010) Indian J. Pharm. Sci., 72(1), 101–105. Scholar google search
Gohel M., Sarvaiya K.G. (2007) AAPS Pharm. Sci. Tech., 8(3), E 68. Scholar google search
Bhise S.B., More A.B., Rajkumar M. (2010) Sci. Pharm., 78, 291-302. Scholar google search
Gupta S., Kumar P., Gupta M.K., Vyas S. (2012) Crit. Rev. Ther. Drug Carrier Syst., 29(4), 299-353. Scholar google search
Shegokar R., Al Shaal L., Mitri K. (2011) J. Pharm. Pharmaceut. Sci., 14(1), 100–116. Scholar google search
Willis L., Hayes D.Jr., Mansour H.M. (2012) Lung, 190(3), 251-262. Scholar google search
Ahmed M., Ramadan W., Rambhu D., Shakeel F. (2008) Pharmazie, 63(11), 806-811. Scholar google search
Pandey R., Zahoor A., Sharma S., Khuller G.K. (2003) Tuberculosis (Edinb), 83(6), 373-378. Scholar google search
